Literature DB >> 7523304

Some structures and processes of human epithelial cells involved in uptake of enterohemorrhagic Escherichia coli O157:H7 strains.

T A Oelschlaeger1, T J Barrett, D J Kopecko.   

Abstract

Several enterohemorrhagic Escherichia coli (EHEC) strains of serotype O157:H7 isolated from patients with hemorrhagic colitis, ischemic colitis, or hemolytic uremic syndrome were all found to be able to invade certain human epithelial cell lines in vitro. Their ability to gain entry into epithelial cells was compared with those of known invasive Shigella flexneri and Salmonella typhi strains and the noninvasive E. coli strain HB101 in invasion assays utilizing gentamicin to kill extracellular bacteria. All EHEC strains under investigation were efficiently internalized into T24 bladder and HCT-8 ileocecal cells. In striking contrast to shigellae, the same EHEC strains were not taken up into human embryonic intestinal INT407 cells or HEp-2 cells any more than the noninvasive E. coli strain HB101. The mechanism(s) of EHEC internalization was characterized by comparing the invasion efficiencies in the absence and presence of a variety of inhibitors acting on structures and processes of prokaryotic or eukaryotic cells. Also, wild-type, plasmid-containing EHEC strains were compared with their plasmid-cured isogenic derivative strains to determine if plasmid genes affect invasion ability. Plasmid-cured EHEC invaded as well as wild-type EHEC, indicating that invasion ability is chromosomally encoded. Inhibition of bacterial protein synthesis by simultaneous addition of bacteria and chloramphenicol to the monolayer blocked EHEC uptake dramatically, suggesting the presence of an invasion protein(s) with a short half-life. Studies utilizing inhibitors which act on eukaryotic cells demonstrated a strong dependence on microfilaments in the process of uptake of all EHEC strains into both T24 and HCT-8 cells. In general, depolymerization of microtubules as well as inhibition of receptor-mediated endocytosis reduced the efficiency of EHEC invasion of T24 cells, whereas interference with endosome acidification reduced EHEC entry into only HCT-8 cells. Taxol-induced stabilization of microtubules did not inhibit internalization into T24 cells or into the HCT-8 cell line. In marked contrast, the ability of S. typhi Ty2 to invade either cell line was inhibited only by depolymerization of microfilaments. In addition to the cell line specificity of EHEC invasion, not all EHEC strains displayed uniform behavior in the presence of inhibitors, suggesting the existence of variant uptake pathways in different strains. Most importantly, previous reports of the inability of EHEC to invade INT407 or HEp-2 cell lines support the currently held belief that EHEC strains are noninvasive.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523304      PMCID: PMC303236          DOI: 10.1128/iai.62.11.5142-5150.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.

Authors:  P M Griffin; R V Tauxe
Journal:  Epidemiol Rev       Date:  1991       Impact factor: 6.222

2.  A comparison of HEp-2 cell invasion by enteropathogenic and enteroinvasive Escherichia coli.

Authors:  M S Donnenberg; A Donohue-Rolfe; G T Keusch
Journal:  FEMS Microbiol Lett       Date:  1990-05       Impact factor: 2.742

3.  Molecular cloning of epithelial cell invasion determinants from enterotoxigenic Escherichia coli.

Authors:  E A Elsinghorst; D J Kopecko
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

4.  Characterization of interactions of enteropathogenic Escherichia coli O127:H6 with mammalian cells in vitro.

Authors:  C L Francis; A E Jerse; J B Kaper; S Falkow
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

5.  Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  J Yu; J B Kaper
Journal:  Mol Microbiol       Date:  1992-02       Impact factor: 3.501

6.  Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family.

Authors:  J E Galán; C Ginocchio; P Costeas
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

7.  Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii.

Authors:  T A Oelschlaeger; P Guerry; D J Kopecko
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Interaction of L cells and Chlamydia psittaci: entry of the parasite and host responses to its development.

Authors:  R R Friis
Journal:  J Bacteriol       Date:  1972-05       Impact factor: 3.490

9.  Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein.

Authors:  J M Leong; R S Fournier; R R Isberg
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites.

Authors:  T C Jones; J G Hirsch
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

View more
  25 in total

1.  Intracellular growth in Acanthamoeba castellanii affects monocyte entry mechanisms and enhances virulence of Legionella pneumophila.

Authors:  J D Cirillo; S L Cirillo; L Yan; L E Bermudez; S Falkow; L S Tompkins
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules.

Authors:  J Guignot; M F Bernet-Camard; C Poüs; L Plançon; C Le Bouguenec; A L Servin
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Ability of Escherichia coli isolates that cause meningitis in newborns to invade epithelial and endothelial cells.

Authors:  C Meier; T A Oelschlaeger; H Merkert; T K Korhonen; J Hacker
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease.

Authors:  J Boudeau; A L Glasser; E Masseret; B Joly; A Darfeuille-Michaud
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Adherence to and invasion of tissue culture cells by Vibrio hollisae.

Authors:  M D Miliotis; B D Tall; R T Gray
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  Physical limitations on Salmonella typhi entry into cultured human intestinal epithelial cells.

Authors:  X Z Huang; B Tall; W R Schwan; D J Kopecko
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

7.  Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract.

Authors:  T A Oelschlaeger; B D Tall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

8.  Pas, a novel protein required for protein secretion and attaching and effacing activities of enterohemorrhagic Escherichia coli.

Authors:  A U Kresse; K Schulze; C Deibel; F Ebel; M Rohde; T Chakraborty; C A Guzmán
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

9.  The type 4 pili of enterohemorrhagic Escherichia coli O157:H7 are multipurpose structures with pathogenic attributes.

Authors:  Juan Xicohtencatl-Cortes; Valério Monteiro-Neto; Zeus Saldaña; Maria A Ledesma; Jose Luís Puente; Jorge A Girón
Journal:  J Bacteriol       Date:  2008-10-24       Impact factor: 3.490

10.  Signal transduction responses following adhesion of verocytotoxin-producing Escherichia coli.

Authors:  A Ismaili; D J Philpott; M T Dytoc; P M Sherman
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.